UroGen Pharma (URGN) Raw Materials (2020 - 2021)

UroGen Pharma (URGN) has 2 years of Raw Materials data on file, last reported at $2.4 million in Q1 2021.

• Quarterly Raw Materials changed N/A year-over-year to $2.4 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $2.4 million (changed N/A YoY) and the FY2020 annual result came in at $1.1 million, changed N/A from the prior year.
• Raw Materials grew to $2.4 million in Q1 2021, from $1.1 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.4 million in Q1 2021 to a low of $893000.0 in Q2 2020.